Organization Overview
Historical Acquisition Tree
Alternative names
alitretinoin (panretin) (1999 NDA)
bexarotene (targretin) (1999 NDA)
Key: Ligand Pharmaceuticals (6) Acquired (1)
Key: Ligand Pharmaceuticals (10) Acquired (8)
Key: Ligand Pharmaceuticals (2) Acquired (3)
Alopecia (Phase 3)
Alopecia Areata (Phase 3)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Epilepsy (Phase 3)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis B (Phase 1)
Hepatitis B, Chronic (Phase 1)
Hepatitis, Chronic (Phase 1)
Hypercholesterolemia (Phase 2)
Hypertension (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Cutaneous (Phase 4)
Mycoses (Phase 4)
Mycosis Fungoides (Phase 4)
Osteoporosis (Phase 3)
Osteoporosis, Postmenopausal (Phase 2)
Parapsoriasis (Phase 2)
Parkinson Disease (Phase 2)
Psoriasis (Phase 2)
Psychomotor Agitation (Phase 2)
Renal Insufficiency (Phase 2)
Restless Legs Syndrome (Phase 2)
Rhinitis (Phase 2)
Rhinitis, Allergic (Phase 2)
Rhinitis, Allergic, Seasonal (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sezary Syndrome (Phase 4)
Syndrome (Phase 2)